Speaking of Sanofi: A Blog for Pharma Aficionados
"Dear friends, employees, and pharma aficionados..."
That's how Stacy Burch, Director, Corporate Reputation and Digital Communications, at Sanofi US, began the first post to her company's new blog Speaking of Sanofi (read "Speaking...
Many Smartphone Apps Lack Privacy Policies
"California's attorney general filed a first-ever privacy lawsuit against the maker of a smartphone application, a move that could shape how the nascent app industry handles personal information," reports the Wall...
Are Today’s Social Media Sites Helpful in Managing Chronic Diseases Like Diabetes?
In an "Open letter to NPR about Diabetes Social Media piece," Kerri Morrone Sparling of Six Until Me, attempts to refute a claim made by Jason Bronner, a doctor at the...
What’s at Stake in the Off-Label Promotion Debate: It’s NOT Free Speech!
In case you haven't heard, in a 2-to-1 split decision, the 2nd U.S. Circuit Court of Appeals in New York on Monday threw out the conviction of a sales representative for...
Google’s NEW Rx Drug Search Results Page Raises Question: Will It Spur New, Favorable...
Last year I posted data that showed Google's OneBox Rx "Ads" steal clicks from organic branded Rx search results (see chart below).
I just learned that Google has gone one step further....
Dear Santa from Pharma: “Please, Sir, May I Have More?”
In the "Pharma's 2011 Christmas Wish List for Santa" survey, I had a list of items for Santa to deliver to the pharmaceutical industry. Naughty or nice, the drug industry did...
FDA’s “Social Media Guidance Cliff”: An Open Letter to Megan Clark Velez
FDA will communicate its progress towards accomplishing the requirements of the FDA Safety and Innovation Act (FDASIA) by updating an online chart/database on a regular basis. This database/website is called FDASIA-TRACK.
Currently,...
Pharma’s Adherence Revenue Pipe Dream
You've seen the headlines:
"Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to Medication Non-Adherence"
"Poor adherence costs pharma $564 billion per year"
These numbers come...
U.S. Brand Drug Prices Take Flight While Generic Prices Plummet
Express Scripts just published its "Inaugural Drug Trend Quarterly," which provides the "first comprehensive overview of U.S. prescription drug spending for 2012 (see press release here). The key findings include:
The Index...
What Pharma Can Learn from Dexter
Pharma marketers are often urged to learn from other industries. Well, I have something that pharma marketers/communicators can learn from Dexter, "America's favorite serial killer."
No, I'm not suggesting that marketers adopt...
